ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
38 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The companys products and technology include GeneICE-silencing rebellious genes, GeneICE BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401-lung cancer. It operates through its three business divisional companies. ValiRxs ValiMedix sells and distributes oncology therapeutics. The companys ValiPharma is a therapeutics division that provides technologies for the treatment of cancer. Itss ValiFinn offers research and development services.

ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal ty

  
Source:
Document ID
GDPH58208D
Country
Industry
Ticker
VAL=GB
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
ValiRx Plc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
ValiRx Plc, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
ValiRx Plc, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
ValiRx Plc, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
ValiRx Plc, Medical Devices Deals, 2010 to YTD 201691
ValiRx Plc, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
ValiRx Plc, Pharmaceuticals &Healthcare, Deal Details1124
  Asset Purchase111
    ValiRx Acquires TRAC Biomarker Technology for USD1 Million111
  Partnerships121
    ValiRx Enters into Co-Development Agreement with Pharmatest Services121
    ValiRx Enters into Agreement with German Cancer Research Center for VAL-101131
    ValiRx Forms Joint Venture With Tangent Reprofiling141
    ValiRx Enters Into Co-Development Agreement With Imperial College London151
    ValiRx Enters Into Co-Development Agreement With Oxford University161
  Equity Offering171
    ValiRx Raises USD0.7 Million in Private Placement of Shares171
    ValiRx Raises USD3.8 Million in Private Placement of Shares182
    ValiRx Raises USD1.2 Million in Private Placement of Shares202
    ValiRx Completes Private Placement of Shares for USD1.3 Million222
    ValiRx Completes Private Placement Of Shares For US$4.75 Million242
    ValiRx Completes Private Placement Of Shares For US$1.6 Million261
    ValiRx Completes Private Placement Of Shares For 1.4 Million271
    ValiRx Completes Private Placement Of US$4.94 Million282
    ValiRx Completes Private Placement Of US$0.41 Million301
    ValiRx Completes Private Placement Of US$0.76 Million311
    ValiRx Completes Private Placement Of US$0.004 Million322
  Acquisition341
    ValiRx Divests Its Stake In VolitionRx For US$0.6 Million341
ValiRx Plc - Key Competitors351
Key Employees361
Locations And Subsidiaries371
  Head Office371
  Other Locations &Subsidiaries371
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ValiRx-Plc-VAL-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13960>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). ValiRx Plc (VAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ValiRx-Plc-VAL-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13960>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research